跳到正文
原文
Endpoints News 生物医药· Alex Hoffman·· 28 天前AI 评分30

Al Sandrock 将于明年第一季度卸任 Voyager Therapeutics CEO;Insmed 任命 Paul Hudson 加入董事会

Al Sandrock to step down as Voyager CEO; Insmed adds Paul Hudson to board

AI 导读

Voyager Therapeutics CEO Al Sandrock 将于明年第一季度卸任,但仍留任董事会成员。与此同时,Insmed 宣布任命 Paul Hudson 加入其董事会。

正文

→ Al San­drock is call­ing it quits as CEO of Voy­ager Ther­a­peu­tics in the first quar­ter next year, but he will stay on the board …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news